Firsts Home

Equity & Derivatives Companies, sectors, M&A and the financial industry
Canada’s Medicago jumps after Reuters interview on swine flu vaccine deal 08.31.2009 Shares of Canadian biotech company Medicago soared 33 percent to a year high on Aug. 31 after Reuters exclusively reported news of a licensing agreement of its swine flu vaccine with a company in the Middle East. The company’s chief executive also said in an interview that Medicago planned to start talks soon with China’s Hunan province on developing a vaccine. Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here	firsts across any industry Commodities & Energy Energy, metals, agricultural and environmental markets FX & Money Markets Macroeconomics, monetary policy, FX and money markets Politics & Risk Politics and political risk Equity & Derivatives Companies, sectors, M&A and the financial industry Fixed Income Sovereign and corporate debt, credit, and ratings firsts by region Americas View stories from this region Europe / Middle East / Africa View stories from this region Asia View stories from this region Emerging Markets View stories from this region

Equity & Derivatives

Companies, sectors, M&A and the financial industry

Canada’s Medicago jumps after Reuters interview on swine flu vaccine deal

08.31.2009

Shares of Canadian biotech company Medicago soared 33 percent to a year high on Aug. 31 after Reuters exclusively reported news of a licensing agreement of its swine flu vaccine with a company in the Middle East. The company’s chief executive also said in an interview that Medicago planned to start talks soon with China’s Hunan province on developing a vaccine.

Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here